Literature DB >> 8688919

Immunofluorescence and immunoblot studies on the reactivity of pemphigus vulgaris and pemphigus foliaceus sera with desmoglein 3 and desmoglein 1.

T Hashimoto1, M Amagai, D R Garrod, T Nishikawa.   

Abstract

We have investigated expression of pemphigus vulgaris (PV) antigen, desmoglein 3 (Dsg3), and pemphigus foliaceus (PF) antigen, desmoglein 1 (Dsg1), in various tissues. Immunofluorescence studies suggested that Dsg1 and Dsg3 are preferentially expressed in the upper and lower epidermis, respectively. With immunoblotting of human epidermal extracts, all PV sera reacted with Dsg3 but not with Dsg1. By contrast, only half of PF sera reacted with Dsg1 but none reacted with Dsg3. These results confirm the distinct antibody specificity between PV and PF sera. They also suggest that PV sera contain antibodies against linear epitopes present even on the denatured antigen, while some PF sera contain antibodies only against conformational epitopes present on the native antigen. With immunoblotting of bovine desmosome preparations, certain PV sera and an anti-Dsg monoclonal antibody reacted with both Dsg1 and Dsg3. Affinity-purification of these PV antibodies suggested that the simultaneous reactivity with Dsg1 and Dsg3 was produced by two different subsets of antibodies and not by cross-reactivity of single antibodies. This study indicates that pemphigus serum is a useful probe with which we learn various aspects of keratinocyte biology.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8688919

Source DB:  PubMed          Journal:  Epithelial Cell Biol        ISSN: 0940-9912


  7 in total

Review 1.  Update on fogo selvagem, an endemic form of pemphigus foliaceus.

Authors:  Valeria Aoki; Evandro A Rivitti; Luis A Diaz
Journal:  J Dermatol       Date:  2015-01       Impact factor: 4.005

2.  Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions.

Authors:  V T Nguyen; A Ndoye; L D Shultz; M R Pittelkow; S A Grando
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

3.  Treatment of oral pemphigoid with intravenous immunoglobulin as monotherapy. Long-term follow-up: influence of treatment on antibody titres to human alpha6 integrin.

Authors:  N Sami; K C Bhol; A R Ahmed
Journal:  Clin Exp Immunol       Date:  2002-09       Impact factor: 4.330

4.  Proteomic definition of a desmoglein linear determinant common to Pemphigus vulgaris and Pemphigus foliaceous.

Authors:  Alberta Lucchese; Abraham Mittelman; Luciana Tessitore; Rosario Serpico; Animesh A Sinha; Darja Kanduc
Journal:  J Transl Med       Date:  2006-08-22       Impact factor: 5.531

5.  Pemphigus vulgaris presented with cheilitis.

Authors:  Zaheer Abbas; Zahra Safaie Naraghi; Elham Behrangi
Journal:  Case Rep Dermatol Med       Date:  2014-09-25

6.  Modifications of the Transcriptomic Profile of Autoreactive B Cells From Pemphigus Patients After Treatment With Rituximab or a Standard Corticosteroid Regimen.

Authors:  Vivien Hébert; Marie Petit; Maud Maho-Vaillant; Marie-Laure Golinski; Gaëtan Riou; Céline Derambure; Olivier Boyer; Pascal Joly; Sébastien Calbo
Journal:  Front Immunol       Date:  2019-08-07       Impact factor: 7.561

Review 7.  Immunopathology and molecular diagnosis of autoimmune bullous diseases.

Authors:  Sidonia Mihai; Cassian Sitaru
Journal:  J Cell Mol Med       Date:  2007 May-Jun       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.